AmCad BioMed Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	9.58	24.6	17.76	29.66	47.04	58.51
Short-Term Investments	339.61	340.62	339.95	252.61	280.78	312.54
Trading Asset Securities	-	-	4	5	3.02	-
Cash & Short-Term Investments	349.19	365.22	361.71	287.27	330.84	371.05
Cash Growth	-14.23%	0.97%	25.91%	-13.17%	-10.84%	-6.09%
Accounts Receivable	6.14	9.34	20.66	11.35	4.51	5.78
Other Receivables	0.03	0.02	0.01	-	0.06	0.13
Receivables	6.17	9.37	20.66	11.35	4.57	5.91
Inventory	28.63	27.34	30.09	25.02	23.33	21.24
Prepaid Expenses	1.82	2.04	1.28	2.07	1.02	2.03
Other Current Assets	6.1	6.03	4.34	0.18	0.12	0.31
Total Current Assets	391.91	410	418.09	325.89	359.88	400.54
Property, Plant & Equipment	83.84	75.21	82.92	82.71	79.81	88.23
Long-Term Investments	70.3	75.8	125.68	28.06	28.74	34.47
Goodwill	31.18	31.18	31.18	31.18	31.18	31.18
Other Intangible Assets	27.1	28.77	35.15	42.5	50.54	58.62
Other Long-Term Assets	1.82	1.75	1.87	2.3	3.72	2.72
Total Assets	606.14	622.7	694.87	512.65	553.86	615.75
Accounts Payable	1.83	1.32	2.74	1.95	1.06	1.15
Accrued Expenses	5.84	-	-	-	-	-
Current Portion of Leases	4.69	1.31	5.15	4.4	3.88	4.42
Current Unearned Revenue	0.94	0.46	0.51	2.05	2.67	5.45
Other Current Liabilities	3.57	15.04	16.75	16.02	19.75	15.11
Total Current Liabilities	16.87	18.13	25.14	24.42	27.36	26.13
Long-Term Leases	9.81	3.44	5.72	9.99	6.43	10.31
Other Long-Term Liabilities	0.32	0.32	0.29	0.29	0.29	0.28
Total Liabilities	27	21.88	31.16	34.7	34.08	36.72
Common Stock	633.33	633.33	633.33	532.56	532.21	532.21
Additional Paid-In Capital	142.29	142.17	141.52	8.02	95.74	94.92
Retained Earnings	-266.6	-253.08	-199.32	-148.74	-192.06	-138.57
Comprehensive Income & Other	-6.49	-0.99	-6.88	-11.25	-11.32	-5.59
Total Common Equity	502.53	521.42	568.65	380.58	424.58	482.98
Minority Interest	76.61	79.4	95.07	97.37	95.2	96.06
Shareholders' Equity	579.14	600.82	663.72	477.95	519.78	579.03
Total Liabilities & Equity	606.14	622.7	694.87	512.65	553.86	615.75
Total Debt	14.5	4.75	10.87	14.39	10.31	14.73
Net Cash (Debt)	334.69	360.47	350.84	272.88	320.53	356.32
Net Cash Growth	-16.05%	2.75%	28.57%	-14.87%	-10.04%	-8.84%
Net Cash Per Share	5.28	5.69	6.08	5.13	6.02	6.70
Filing Date Shares Outstanding	63.33	63.33	63.33	53.26	53.22	53.22
Total Common Shares Outstanding	63.33	63.33	63.33	53.26	53.22	53.22
Working Capital	375.04	391.87	392.94	301.47	332.52	374.41
Book Value Per Share	7.93	8.23	8.98	7.15	7.98	9.07
Tangible Book Value	444.26	461.48	502.33	306.9	342.87	393.18
Tangible Book Value Per Share	7.01	7.29	7.93	5.76	6.44	7.39
Land	52.94	52.94	52.94	52.94	52.94	52.94
Buildings	8.14	8.14	8.14	8.14	8.14	8.14
Machinery	15.59	14.99	15.57	25.15	48.47	47.34
Leasehold Improvements	-	-	-	-	0.82	0.82